Skip to main content
Erschienen in:

10.06.2016 | Review Article

Challenges in pancreas transplantation

verfasst von: E. J. Sharples, S. M. Mittal, P. J. Friend

Erschienen in: Acta Diabetologica | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Whole-organ pancreas transplantation, either alone or combined with a kidney transplant, is the only definitive treatment for many patients with type 1 diabetes that restores normal glucose homoeostasis and insulin independence. Pancreas transplantation delays, or potentially prevents, secondary diabetes complications and is associated with improvement in patient survival when compared with either patients remaining on the waiting list or those receiving kidney transplant alone. Pancreas transplantation is safe and effective, with 1-year patient survival >97 % and graft survival rates of 85 % at 1 year and 76 % at 5 years in recent UK data. This review focuses on some current areas of interest in pancreas transplantation.
Literatur
2.
Zurück zum Zitat Patterson CC, Dahlquist GC et al (2009) Incidence trends for childhood type 1 diabetes in Europe during 1983–2993 and predicted new cases 2005–2020: a multicentre prospective registration study. Lancet 373:2027CrossRefPubMed Patterson CC, Dahlquist GC et al (2009) Incidence trends for childhood type 1 diabetes in Europe during 1983–2993 and predicted new cases 2005–2020: a multicentre prospective registration study. Lancet 373:2027CrossRefPubMed
3.
Zurück zum Zitat Imperatore G, Boyle JP, SEARCH for Diabetes in Youth study group et al (2012) Projections of type 1 and type 2 diabetes burden in the US population aged <20 years through 2050. Diabetes Care 35:2515CrossRefPubMedPubMedCentral Imperatore G, Boyle JP, SEARCH for Diabetes in Youth study group et al (2012) Projections of type 1 and type 2 diabetes burden in the US population aged <20 years through 2050. Diabetes Care 35:2515CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Gregg E, Li Y et al (2014) Changes in diabetes-related complications in the United States, 1990–2010. N Engl J Med 370:1514CrossRefPubMed Gregg E, Li Y et al (2014) Changes in diabetes-related complications in the United States, 1990–2010. N Engl J Med 370:1514CrossRefPubMed
6.
Zurück zum Zitat Preis SR, Hwang S-J et al (2009) Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950–2005. Circulation 119:1728–1735CrossRefPubMedPubMedCentral Preis SR, Hwang S-J et al (2009) Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950–2005. Circulation 119:1728–1735CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Gruessner RWG, Gruessner AC (2013) The current state of pancreas transplantation. Nat Rev Endocrinol 3:555CrossRef Gruessner RWG, Gruessner AC (2013) The current state of pancreas transplantation. Nat Rev Endocrinol 3:555CrossRef
9.
Zurück zum Zitat Redfield RR, Scalea JR, Odorico JS (2015) Simultaneous pancreas and kidney transplantation: current trends and future directions. Curr Opin Organ Transplant 20:94–102CrossRefPubMedPubMedCentral Redfield RR, Scalea JR, Odorico JS (2015) Simultaneous pancreas and kidney transplantation: current trends and future directions. Curr Opin Organ Transplant 20:94–102CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Vaidya A, Muthusamy AS, Hadjianastassiou VG et al (2007) Simultaneous pancreas kidney transplantation: to anticoagulate or not? Is that a question? Clin Transplant 21:554–557CrossRefPubMed Vaidya A, Muthusamy AS, Hadjianastassiou VG et al (2007) Simultaneous pancreas kidney transplantation: to anticoagulate or not? Is that a question? Clin Transplant 21:554–557CrossRefPubMed
11.
Zurück zum Zitat Gruessner AC, Gruessner RWG (2012) Pancreas transplant outcomes for the United States and non-United States cases as reported to the United Network for Organ Sharing and the International Pancreas transplant registry as of December 2011. Clin Transpl, p 23 Gruessner AC, Gruessner RWG (2012) Pancreas transplant outcomes for the United States and non-United States cases as reported to the United Network for Organ Sharing and the International Pancreas transplant registry as of December 2011. Clin Transpl, p 23
12.
Zurück zum Zitat Kandaswamy R, Skeans MA et al (2015) OPTN/SRTR 2013 annual data report: pancreas. Am J Transplant 15(S2):1–20CrossRefPubMed Kandaswamy R, Skeans MA et al (2015) OPTN/SRTR 2013 annual data report: pancreas. Am J Transplant 15(S2):1–20CrossRefPubMed
13.
Zurück zum Zitat National Clinical Guideline Centre (UK) (2015) Type 1 diabetes in adults: type 1 diabetes in adults: diagnosis and management. National Institute for Health and Care Excellence (UK), London National Clinical Guideline Centre (UK) (2015) Type 1 diabetes in adults: type 1 diabetes in adults: diagnosis and management. National Institute for Health and Care Excellence (UK), London
14.
Zurück zum Zitat Elwen FR, Huskinson A et al (2015) An observational study of patient characteristics and mortality following hypoglycemia in the community. BMJ Open Diabetes Res Care 3:e000094CrossRefPubMedPubMedCentral Elwen FR, Huskinson A et al (2015) An observational study of patient characteristics and mortality following hypoglycemia in the community. BMJ Open Diabetes Res Care 3:e000094CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Khunti K, Davies M et al (2015) Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study. Diabetes Care 38:316CrossRefPubMed Khunti K, Davies M et al (2015) Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study. Diabetes Care 38:316CrossRefPubMed
16.
Zurück zum Zitat Groop PH, Thomas MC, FinnDiane Study Group et al (2009) The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. Diabetes 58:1651–1658CrossRefPubMedPubMedCentral Groop PH, Thomas MC, FinnDiane Study Group et al (2009) The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. Diabetes 58:1651–1658CrossRefPubMedPubMedCentral
17.
18.
Zurück zum Zitat Haapio M, Helve J et al (2010) Survival of patients with type 1 diabetes receiving renal replacement therapy 1980–2007. Diabetes Care 33:1718–1723CrossRefPubMedPubMedCentral Haapio M, Helve J et al (2010) Survival of patients with type 1 diabetes receiving renal replacement therapy 1980–2007. Diabetes Care 33:1718–1723CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Rana A, Gruessner A et al (2015) Survival benefit of solid-organ transplant in the United States. JAMA Surg 150:252–259CrossRefPubMed Rana A, Gruessner A et al (2015) Survival benefit of solid-organ transplant in the United States. JAMA Surg 150:252–259CrossRefPubMed
20.
Zurück zum Zitat Weiss AS, Smits G, Wiseman AC (2009) Simultaneous pancreas-kidney versus deceased donor kidney transplant: Can a fair comparison be made? Transplantation 87:1402–1410CrossRefPubMed Weiss AS, Smits G, Wiseman AC (2009) Simultaneous pancreas-kidney versus deceased donor kidney transplant: Can a fair comparison be made? Transplantation 87:1402–1410CrossRefPubMed
21.
Zurück zum Zitat Weiss AS, Smits G, Wiseman AC (2009) Twelve-month pancreas graft function significantly influences survival following simultaneous pancreas-kidney transplantation. Clin J Am Soc Nephrol 4:988–995CrossRefPubMedPubMedCentral Weiss AS, Smits G, Wiseman AC (2009) Twelve-month pancreas graft function significantly influences survival following simultaneous pancreas-kidney transplantation. Clin J Am Soc Nephrol 4:988–995CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Wiseman AC, Huang E, Kamgar M, Bunnapradist S (2013) The impact of pre-transplant dialysis on simultaneous pancreas-kidney versus living donor kidney transplant outcomes. Nephrol Dial Transplant 28:1047–1058CrossRefPubMed Wiseman AC, Huang E, Kamgar M, Bunnapradist S (2013) The impact of pre-transplant dialysis on simultaneous pancreas-kidney versus living donor kidney transplant outcomes. Nephrol Dial Transplant 28:1047–1058CrossRefPubMed
23.
Zurück zum Zitat Sung RS, Zhang M, Schaubel DE, Shu X, Magee JC (2015) A reassessment of the survival advantage of simultaneous kidney-pancreas versus kidney-alone transplantation. Transplantation 99:1900–1906CrossRefPubMedPubMedCentral Sung RS, Zhang M, Schaubel DE, Shu X, Magee JC (2015) A reassessment of the survival advantage of simultaneous kidney-pancreas versus kidney-alone transplantation. Transplantation 99:1900–1906CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Kahn SE, Cooper ME, Del Prato S (2014) Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet 383:1068–1083CrossRefPubMed Kahn SE, Cooper ME, Del Prato S (2014) Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet 383:1068–1083CrossRefPubMed
25.
Zurück zum Zitat Covic AM, Schelling JR, Constantiner M, Iyengar SK, Sedor JR (2000) Serum C-peptide concentrations poorly phenotype type 2 diabetic end-stage renal disease patients. Kidney Int 58:1742–1750CrossRefPubMed Covic AM, Schelling JR, Constantiner M, Iyengar SK, Sedor JR (2000) Serum C-peptide concentrations poorly phenotype type 2 diabetic end-stage renal disease patients. Kidney Int 58:1742–1750CrossRefPubMed
26.
Zurück zum Zitat Sasaki TM, Gray RS et al (1998) Successful long-term kidney-pancreas transplants in diabetic patients with high C-peptide levels. Transplantation 65:1510–1512CrossRefPubMed Sasaki TM, Gray RS et al (1998) Successful long-term kidney-pancreas transplants in diabetic patients with high C-peptide levels. Transplantation 65:1510–1512CrossRefPubMed
27.
Zurück zum Zitat Wiseman AC, Gralla J (2012) Simultaneous pancreas kidney transplant versus other kidney transplant options in patients with type 2 diabetes. Clin J Am Soc Nephrol 7:656–664CrossRefPubMed Wiseman AC, Gralla J (2012) Simultaneous pancreas kidney transplant versus other kidney transplant options in patients with type 2 diabetes. Clin J Am Soc Nephrol 7:656–664CrossRefPubMed
28.
Zurück zum Zitat Stratta RJ, Rogers J et al (2015) Pancreas transplantation in C-peptide positive patients: Does “type” of diabetes really matter? J Am Coll Surg 220:716–727CrossRefPubMed Stratta RJ, Rogers J et al (2015) Pancreas transplantation in C-peptide positive patients: Does “type” of diabetes really matter? J Am Coll Surg 220:716–727CrossRefPubMed
29.
Zurück zum Zitat Ciancio G, Burke GW (2014) Type 2 diabetes: Is pancreas transplantation an option? Curr Diabetes Rep 14:542CrossRef Ciancio G, Burke GW (2014) Type 2 diabetes: Is pancreas transplantation an option? Curr Diabetes Rep 14:542CrossRef
30.
Zurück zum Zitat Denecke C (2015) The bionic pancreas: novel perspectives on insulin replacement therapies. Transplantation 99:268–269CrossRefPubMed Denecke C (2015) The bionic pancreas: novel perspectives on insulin replacement therapies. Transplantation 99:268–269CrossRefPubMed
31.
32.
Zurück zum Zitat Fiorina P, Vezzulli P, Bassi R et al (2012) Near normalization of metabolic and functional features of the central nervous system in type 1 diabetic patients with end-stage renal disease after kidney-pancreas transplantation. Diabetes Care 35:367–374CrossRefPubMedPubMedCentral Fiorina P, Vezzulli P, Bassi R et al (2012) Near normalization of metabolic and functional features of the central nervous system in type 1 diabetic patients with end-stage renal disease after kidney-pancreas transplantation. Diabetes Care 35:367–374CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Gremizzi C, Vergani A, Paloschi V, Secchi A (2010) Impact of pancreas transplantation on type 1 diabetes-related complications. Curr Opin Organ Transplant 15:119–123CrossRefPubMed Gremizzi C, Vergani A, Paloschi V, Secchi A (2010) Impact of pancreas transplantation on type 1 diabetes-related complications. Curr Opin Organ Transplant 15:119–123CrossRefPubMed
34.
Zurück zum Zitat Perseghin G, Fiorina P, De Cobelli F et al (2005) Cross-sectional assessment of the effect of kidney and kidney-pancreas transplantation on resting left ventricular energy metabolism in type 1 diabetic-uremic patients: a phosphorous-31 magnetic resonance spectroscopy study. J Am Coll Cardiol 46:1085–1092CrossRefPubMed Perseghin G, Fiorina P, De Cobelli F et al (2005) Cross-sectional assessment of the effect of kidney and kidney-pancreas transplantation on resting left ventricular energy metabolism in type 1 diabetic-uremic patients: a phosphorous-31 magnetic resonance spectroscopy study. J Am Coll Cardiol 46:1085–1092CrossRefPubMed
35.
Zurück zum Zitat Lindahl JP, Hartmann A, Aakhus S et al (2016) Long-term cardiovascular outcomes in type 1 diabetic patients after simultaneous pancreas and kidney transplantation compared with living donor kidney transplantation. Diabetologia 59:844–852CrossRefPubMed Lindahl JP, Hartmann A, Aakhus S et al (2016) Long-term cardiovascular outcomes in type 1 diabetic patients after simultaneous pancreas and kidney transplantation compared with living donor kidney transplantation. Diabetologia 59:844–852CrossRefPubMed
36.
Zurück zum Zitat Dieterle CD, Arbogast H et al (2007) Metabolic follow-up after long term pancreas graft survival. Eur J Endocrinol 156:603–610CrossRefPubMed Dieterle CD, Arbogast H et al (2007) Metabolic follow-up after long term pancreas graft survival. Eur J Endocrinol 156:603–610CrossRefPubMed
37.
Zurück zum Zitat Pfeffer F, Nauck MA et al (2003) Postoperative oral glucose tolerance and stimulated insulin secretion: a predictor of endocrine graft function more than 10 years after pancreas kidney transplantation. Transplantation 76:1427–1431CrossRefPubMed Pfeffer F, Nauck MA et al (2003) Postoperative oral glucose tolerance and stimulated insulin secretion: a predictor of endocrine graft function more than 10 years after pancreas kidney transplantation. Transplantation 76:1427–1431CrossRefPubMed
38.
Zurück zum Zitat Troppmann C, Gruessner AC et al (1996) Delayed endocrine pancreas graft function after simultaneous pancreas-kidney transplantation. Incidence, risk factors, and impact on long-term outcome. Transplantation 61:1323–1330CrossRefPubMed Troppmann C, Gruessner AC et al (1996) Delayed endocrine pancreas graft function after simultaneous pancreas-kidney transplantation. Incidence, risk factors, and impact on long-term outcome. Transplantation 61:1323–1330CrossRefPubMed
39.
Zurück zum Zitat Mittal S, Nagendran M et al (2014) Postoperative impaired glucose tolerance is an early predictor of pancreas graft failure. Diabetologia 57:2076–2080CrossRefPubMed Mittal S, Nagendran M et al (2014) Postoperative impaired glucose tolerance is an early predictor of pancreas graft failure. Diabetologia 57:2076–2080CrossRefPubMed
40.
Zurück zum Zitat Mittal S, Franklin RH et al (2015) Early postoperative continuous glucose monitoring in pancreas transplant recipients. Transpl Int 28:604–609CrossRefPubMed Mittal S, Franklin RH et al (2015) Early postoperative continuous glucose monitoring in pancreas transplant recipients. Transpl Int 28:604–609CrossRefPubMed
41.
Zurück zum Zitat Faradji RN, Froud T et al (2009) Long-term metabolic and hormonal effects of exenatide on islet transplant recipients with allograft dysfunction. Cell Transplant 18(10):1247–1259CrossRefPubMed Faradji RN, Froud T et al (2009) Long-term metabolic and hormonal effects of exenatide on islet transplant recipients with allograft dysfunction. Cell Transplant 18(10):1247–1259CrossRefPubMed
42.
Zurück zum Zitat Wang Y, Qi M et al (2013) Use of glucagon-like peptide-1 agonists to improve islet graft performance. Curr Diabetes Rep 13:723–732CrossRef Wang Y, Qi M et al (2013) Use of glucagon-like peptide-1 agonists to improve islet graft performance. Curr Diabetes Rep 13:723–732CrossRef
43.
44.
Zurück zum Zitat Lerche S, Soendergaard L (2009) No increased risk of hypoglycaemic episodes during 48h of subcutaneous glucagon-like-peptide-1 administration in fasting healthy subjects. Clin Endocrinol 71:500–506CrossRef Lerche S, Soendergaard L (2009) No increased risk of hypoglycaemic episodes during 48h of subcutaneous glucagon-like-peptide-1 administration in fasting healthy subjects. Clin Endocrinol 71:500–506CrossRef
45.
Zurück zum Zitat Cariou B, Bernard C, Cantarovich D (2015) Liraglutide in whole-pancreas transplant patients with impaired glucose homoeostasis: a case series. Diabetes Metab 41:252–257CrossRefPubMed Cariou B, Bernard C, Cantarovich D (2015) Liraglutide in whole-pancreas transplant patients with impaired glucose homoeostasis: a case series. Diabetes Metab 41:252–257CrossRefPubMed
46.
Zurück zum Zitat Dean PG, Kudva YC, Larson TS, Kremers WK, Stegall MD (2008) Post-transplant diabetes mellitus after pancreas transplantation. Am J Transplant 8(1):175–182PubMed Dean PG, Kudva YC, Larson TS, Kremers WK, Stegall MD (2008) Post-transplant diabetes mellitus after pancreas transplantation. Am J Transplant 8(1):175–182PubMed
47.
Zurück zum Zitat Vendrame F, Pileggi A et al (2010) Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells. Diabetes 59:947–957CrossRefPubMedPubMedCentral Vendrame F, Pileggi A et al (2010) Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells. Diabetes 59:947–957CrossRefPubMedPubMedCentral
48.
Zurück zum Zitat Ishida-Oku M, Iwase M et al (2010) A case of recurrent type 1 diabetes mellitus with insulitis of transplanted pancreas in simultaneous pancreas-kidney transplantation from cardiac death donor. Diabetologia 53:341–345CrossRefPubMed Ishida-Oku M, Iwase M et al (2010) A case of recurrent type 1 diabetes mellitus with insulitis of transplanted pancreas in simultaneous pancreas-kidney transplantation from cardiac death donor. Diabetologia 53:341–345CrossRefPubMed
49.
Zurück zum Zitat Braghi S, Bonifacio E, Secchi A, Di Carlo V, Pozza G, Bosi E (2000) Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes. Diabetes 49:218–224CrossRefPubMed Braghi S, Bonifacio E, Secchi A, Di Carlo V, Pozza G, Bosi E (2000) Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes. Diabetes 49:218–224CrossRefPubMed
50.
Zurück zum Zitat Vendrame F, Hopfner YY et al (2016) Risk factors for type 1 diabetes recurrence in immunosuppressed recipients of simultaneous pancreas-kidney transplants. Am J Transplant 16:235–245CrossRefPubMed Vendrame F, Hopfner YY et al (2016) Risk factors for type 1 diabetes recurrence in immunosuppressed recipients of simultaneous pancreas-kidney transplants. Am J Transplant 16:235–245CrossRefPubMed
51.
Zurück zum Zitat Mittal S, Page SL, Friend PJ, Sharples EJ, Fuggle SV (2014) De novo donor-specific HLA antibodies: biomarkers of pancreas transplant failure. Am J Transplant 14:1664–1671CrossRefPubMed Mittal S, Page SL, Friend PJ, Sharples EJ, Fuggle SV (2014) De novo donor-specific HLA antibodies: biomarkers of pancreas transplant failure. Am J Transplant 14:1664–1671CrossRefPubMed
52.
Zurück zum Zitat Drachenberg CB, Papadimitriou JC (2007) Spectrum of histopathological changes in pancreas allograft biopsies and relationship to graft loss. Transplant Proc 39:2326–2328CrossRefPubMed Drachenberg CB, Papadimitriou JC (2007) Spectrum of histopathological changes in pancreas allograft biopsies and relationship to graft loss. Transplant Proc 39:2326–2328CrossRefPubMed
53.
Zurück zum Zitat Papadimitriou JC, Drachenberg CB (2012) Distinctive morphological features of antibody-mediated and T-cell-mediated acute rejection in pancreas allograft biopsies. Curr Opin Organ Transplant 17:93–99CrossRefPubMed Papadimitriou JC, Drachenberg CB (2012) Distinctive morphological features of antibody-mediated and T-cell-mediated acute rejection in pancreas allograft biopsies. Curr Opin Organ Transplant 17:93–99CrossRefPubMed
54.
Zurück zum Zitat León Fradejas M, Kandil D et al (2015) Islet amyloid in whole pancreas transplants for type 1 diabetes mellitus (DM): possible role of type 2 DM for graft failure. Am J Transplant 15:2495–2500CrossRefPubMed León Fradejas M, Kandil D et al (2015) Islet amyloid in whole pancreas transplants for type 1 diabetes mellitus (DM): possible role of type 2 DM for graft failure. Am J Transplant 15:2495–2500CrossRefPubMed
Metadaten
Titel
Challenges in pancreas transplantation
verfasst von
E. J. Sharples
S. M. Mittal
P. J. Friend
Publikationsdatum
10.06.2016
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe 6/2016
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-016-0865-x

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Neue chemotherapiefreie Kombinationstherapie punktet bei CLL

Zwischenergebnisse der Phase-III-Studie AMPLIFY sprechen dafür, dass die zeitlich begrenzte Behandlung mit Acalabrutinib und Venetoclax fitte Personen mit chronischer lymphatischer Leukämie länger leben lässt als eine Chemoimmuntherapie.

NRG1-Fusionen als neues, klinisch relevantes Target

Ergebnisse einer Phase-II-Studie deuten darauf hin, dass ein gegen HER3 und HER2 gerichteter Antikörper bei verschiedenen NRG1-Fusions-positiven Tumoren wirksam sein könnte. In den USA ist die Substanz bereits beschleunigt zugelassen worden.

Die aktuelle S3-Leitlinie zu CLL strotzt vor Neuerungen

Vor kurzem wurde eine neue, grundlegend überarbeite Version der S3-Leitlinie Chronische Lymphatische Leukämie (CLL) veröffentlicht.  Zu den wichtigsten Änderungen gehört, dass die Chemoimmuntherapie auf dem Rückzug ist.

Obinutuzumab verbessert Therapie der Lupus-Nephritis

In einer internationalen Studie führte die zusätzliche Gabe von Obinutuzumab zur Standardtherapie bei fast der Hälfte der Patientinnen und Patienten mit Lupus-Nephritis zu einem vollständigen Ansprechen der Nieren und war damit wirksamer als die Standardtherapie allein.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.